Publication status and disclosure gaps in a cohort of 71 clinical trials assessing the safety and efficacy of 3 COVID-19 vaccines developed by Chinese biopharmaceutical companies: An observational cohort study
View ORCID ProfileTill Bruckner, View ORCID ProfileYixuan Chen, View ORCID ProfileCarolina Cruz, View ORCID ProfileChristie Ebube Dike, View ORCID ProfileBelen Chavarria, View ORCID ProfileShiyu Chen, View ORCID ProfileErnest Dela Dzidzornu, View ORCID ProfileMartin Ringsten
doi: https://doi.org/10.1101/2024.03.17.24304386
Till Bruckner
1UiT The Arctic University of Norway, Tromso, Norway
2TranspariMED, Bristol, UK:
Yixuan Chen
3Independent researcher, Jinhua, China
Carolina Cruz
4University of Guadalajara, Guadalajara, Mexico
Christie Ebube Dike
5Molecular and Genetics Unit, Institute of Child Health, College of Medicine, University of Ibadan, Ibadan, Nigeria
Belen Chavarria
6National Autonomous University of Nicaragua at León, León, Nicaragua
Shiyu Chen
7Independent researcher, London, UK
Ernest Dela Dzidzornu
8Independent researcher, Accra, Ghana
Martin Ringsten
9Cochrane Sweden, Skåne University Hospital, Lund University, Lund, Sweden

Data Availability
Key data produced in the present work are contained in the manuscript (Table 7). All data produced are available online on OSF: https://osf.io/r3vp9/
Posted May 30, 2024.
Publication status and disclosure gaps in a cohort of 71 clinical trials assessing the safety and efficacy of 3 COVID-19 vaccines developed by Chinese biopharmaceutical companies: An observational cohort study
Till Bruckner, Yixuan Chen, Carolina Cruz, Christie Ebube Dike, Belen Chavarria, Shiyu Chen, Ernest Dela Dzidzornu, Martin Ringsten
medRxiv 2024.03.17.24304386; doi: https://doi.org/10.1101/2024.03.17.24304386
Publication status and disclosure gaps in a cohort of 71 clinical trials assessing the safety and efficacy of 3 COVID-19 vaccines developed by Chinese biopharmaceutical companies: An observational cohort study
Till Bruckner, Yixuan Chen, Carolina Cruz, Christie Ebube Dike, Belen Chavarria, Shiyu Chen, Ernest Dela Dzidzornu, Martin Ringsten
medRxiv 2024.03.17.24304386; doi: https://doi.org/10.1101/2024.03.17.24304386
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)